LINCOLN, NE
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NEBRASKA ONCOLOGY SOCIETY, founded in 2010, is a small nonprofit that reported $355K in total revenue in fiscal year 2025. Revenue grew 18% year-over-year, indicating healthy expansion. Expenses of $319K left a modest 10% surplus.
TO ADDRESS EFFECTIVE PRACTICE, RESEARCH, AND OTHER POLICY ISSUES THAT MAY INFLUENCE CLINICAL RESEARCH AND THE QUALIFY OF CARE FOR PEOPLE WITH CANCER.
TO ADDRESS EFFECTIVE PRACTICE, RESEARCH, AND OTHER POLICY ISSUES THAT MAY INFLUENCE CLINICAL RESERACH AND THE QUALITY OF CARE FOR PEOPLE WITH CANCER.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $354,985 | $299,629 | +0.2% |
| Expenses | $319,199 | $204,056 | +0.6% |
| Net Income | $35,786 | $95,573 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STEFANO R TARANTOLO MD | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| RALPH HAUKE MD | IMMEDIATE PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| YUNGPO BERNARD SU MD | SECRETARY/TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SAMER RENNO MD | MEMBER AT LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT LANGDON JR MD | MEMBER AT LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| RYAN RAEMAKERS MD | MEMBER AT LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| IFRAN VAZIRI MD | MEMBER AT LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| MARGARET BLOCK MD | HERMATOLOGY CAC REP | 1.00 |
Director
|
$0 | $0 | $0 |
| CARMEN CHINCHILLA-GUTIERREZ | EXECUTIVE DIRECTOR | 1.00 |
Officer
|
$0 | $0 | $0 |
| AMY REYNOLDSON | EXEC. VP | 1.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $354,985 | $319,199 | $1,654,507 | $35,786 |
| 2024 | $299,629 | $204,056 | $1,618,721 | $95,573 |
| 2023 | $382,910 | $252,442 | $1,532,212 | $130,468 |
| 2022 | $257,327 | $171,244 | $1,401,743 | $86,083 |
| 2021 | $263,096 | $141,255 | $1,315,660 | $121,841 |
| 2020 | $231,841 | $132,403 | $1,193,819 | $99,438 |
| 2019 | $151,971 | $117,134 | $1,094,381 | $34,837 |
| 2018 | $189,999 | $204,980 | $1,059,544 | $-14,981 |
Compare NEBRASKA ONCOLOGY SOCIETY with other nonprofits in Nebraska and across the country.